Article

CRISPR-Cas based biosensors as innovative platforms for diagnosis of human papilloma virus infection

2025-02-06

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d52640fd-8629-5368-adc1-d6266ed147fd
DOI: 10.1016/j.microc.2025.112991

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CRISPR-Cas based biosensors as innovative platforms for diagnosis of human papilloma virus infectionDOI 10.1016/j.microc.2025.112991Read

CRISPR-Cas system: recent advancements in prompt diagnosis of high-risk HPV genotypes in cervical cancer.Semantic proximity Read

Programmable Biosensors Based on RNA-Guided CRISPR/Cas EndonucleaseSemantic proximity Read

Crispr-Cas based biosensing: A fast-expanding molecular diagnostic toolSemantic proximity Read

CRISPR-Cas technology for rapid detection of pathogensSemantic proximity Read

CRISPR-Cas target recognition for sensing viral and cancer biomarkersSemantic proximity Read

CRISPR-Cas based virus detection: Recent advances and perspectivesSemantic proximity Read

A high fidelity CRISPR/Cas12a based lateral flow biosensor for the detection of HPV16 and HPV18Semantic proximity Read

CRISPR/Cas Systems‐Inspired Nano/Biosensors for Detecting Infectious Viruses and Pathogenic BacteriaSemantic proximity Read

Portable, and ultrasensitive HR-HPV tests based on nucleic acid biosensorsSemantic proximity Read

A novel CRISPR/Cas12a biosensor for sensitive detection of Helicobacter pylori from clinical patientsSemantic proximity Read

CRISPR-Cas12a Biosensor Array for Ultrasensitive Detection of Unamplified DNA with Single-Nucleotide Polymorphic Discrimination.Semantic proximity Read

CRISPR/dCas9-mediated biosensor for detection of tick-borne diseasesSemantic proximity Read